FDA
approval
· 2023-05-01
FDA Approved: DALFAMPRIDINE — Supplemental Application (Accord Healthcare Inc.)
Summary
FDA approved Accord Healthcare Inc.'s supplemental application for dalfampridine, approving the generic dalfampridine product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)